Casamento Charles J
SEC-identified person · CIK 1117167 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Eton Pharmaceuticals, Inc. ETON | Director | filed 2018 - 2026 |
| Relmada Therapeutics, INC. RLMD | Director | filed 2015 - 2025 |
| Oxis International INC oxis.ob | Director | filed 2023 - 2025 |
| Paxmedica, Inc. PXMD | Director | filed 2022 - 2024 |
| Gridai Technologies Corp. GRDX | Director | filed 2017 - 2024 |
| International Stem Cell Corp ISCO:OB | Director | filed 2010 - 2018 |
| Supergen INC SUPG | Director | filed 2006 - 2013 |
| Vivus INC vvus | Director | filed 2008 - 2013 |
| Respirerx Pharmaceuticals Inc. corx | Director | filed 2006 - 2012 |
| Osteologix, Inc. OLGX.OB | Director · CEO and President | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.